Welcome to our dedicated page for RADCOM SEC filings (Ticker: RDCM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on RADCOM's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into RADCOM's regulatory disclosures and financial reporting.
Radcom Ltd. (RDCM) submitted a Form 144 reporting a proposed sale of 4,000 common shares through Oppenheimer & Co. with an aggregate market value of $51,600, to be sold approximately on 08/22/2025 on the NASDAQ. The filer acquired the shares as restricted stock units on 02/16/2021 (20,000 units originally awarded). The filing also discloses two recent sales by the same person: 4,062 shares sold 05/29/2025 for $54,837 and 4,000 shares sold 08/15/2025 for $51,160. The notice includes the standard signature representation regarding absence of undisclosed material information.
Radcom Ltd. (RDCM) filed a Form 144 notifying the proposed sale of 6,670 common shares on or about 08/19/2025 through Oppenheimer & Co. at Nasdaq, with an aggregate market value of $87,710.50. The securities were acquired on 10/15/2024 under the company's employee stock options plan and will be paid in cash upon exercise. The filing also discloses recent open-market dispositions by the same holder: 866, 201, 433 and 1,000 shares sold between 05/20/2025 and 08/14/2025, generating listed gross proceeds. The filer affirms no undisclosed material adverse information.
Radcom Ltd. (RDCM) filing a Rule 144 notice shows an insider intends to sell 4,000 common shares through Oppenheimer & Co., valued at $51,200, with an approximate sale date of 08/15/2025 on Nasdaq. The shares were originally acquired as restricted stock units on 02/23/2022, with total RSUs granted of 34,375. The filer also reported two recent sales within the past three months: 3,000 shares on 05/16/2025 for $39,600 and 4,062 shares on 05/29/2025 for $54,837. The notice includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.
RADCOM Ltd. filed a Form 6-K for August 2025 to furnish GAAP financial statements contained in Exhibit 99.1. These financial statements are formally incorporated by reference into the company’s existing Form S-8 registration statements, allowing them to be used in connection with its equity compensation plans.
The filing is an administrative step that links the latest GAAP financial information to several S-8 registrations, and it is signed on behalf of the company by Chief Financial Officer Hadar Rahav.